 |
|
|
 |
|
Rationale:
- Patients may have a number of preconceived notions about psychiatric treatment that make them reluctant to follow through
with effective treatment recommendations; others hope for a quick fix (i.e., medication) for a chronic illness.
|
|
Evidence:
- Clinical experience has found that many patients decline initial offers of treatment for PTSD or drop out of treatment before
they achieve significant benefit. They may be afraid that psychotherapy will make them feel worse as they discuss their traumatic
experiences. Patients taking medications may experience early side effects or become frustrated with the lack of a dramatic
response (1).
|
|
Comments:
|
| FAQs |
|
|
|
Jeffrey P. Staab, MD, MS, is a consultant for Eli Lilly, Forest Laboratories, received honorarium from Abbott Laboratories, received grants from GlaxoSmithKline,
Pfizer. Michael Roy, MD, editorial consultant, received honorarium from PFizer.
|
|
|
|
The information included herein should never be used as a substitute
for clinical judgment and does not represent an official position of
ACP. Because all PIER modules are updated regularly, printed web pages
or PDFs may rapidly become obsolete. Therefore, PIER users should
compare the date of the last update on the website with any printout
to ensure that the information being referred to is the most current
available.
|
PIER is copyrighted (c) 2008 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.
|
|
|
Posttraumatic Stress Disorder
> Patient Education
